• 1
    Gladman DD, Urowitz MB. Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis 1980; 39: 3403.
  • 2
    Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohormonal features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352: 53948.
  • 3
    Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 138898.
  • 4
    Cooper LT, Berry GJ, Shabetai R. Idiopathic giant cell myocarditis: natural history and treatment. N Engl J Med 1997; 336: 18606.
  • 5
    Follansbee WP, Zerbe TR, Medsger TA Jr. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993; 125: 194203.
  • 6
    Doughan AR, Williams BR. Cardiac sarcoidosis. Heart 2006; 92: 2828.
  • 7
    Klippel J, Dieppe P. Rheumatology. 2nd ed. London: Mosby; 1998. p. 2.7, 5.4, 7.9, 7.14.
  • 8
    Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78: 2637.
  • 9
    Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 10
    Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002; 113: 41923.
  • 11
    Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007; 50: 191431.
  • 12
    Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989; 64: 123545.
  • 13
    Virmani R, Burke A, Farb A. Atlas of cardiovascular pathology. Philadelphia: WB Saunders; 1996.
  • 14
    Laufs H, Nigrovic PA, Schneider LC, Oettgen H, del Nido P, Moskowitz IP, et al. Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency. Mayo Clin Proc 2002; 77: 926.
  • 15
    Shariff S, Straatman L, Allard M, Ignaszewski A. Novel associations of giant cell myocarditis: two case reports and a review of the literature. Can J Cardiol 2004; 20: 55761.
  • 16
    Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 2003; 41: 3229.
  • 17
    Chung L, Berry GJ, Chakravarty EF. Giant cell myocarditis: a rare cardiovascular manifestation in a patient with systemic lupus erythematosus. Lupus 2005; 14: 1669.